Wall Street analysts forecast that Sabra Health Care REIT, Inc. (NASDAQ:SBRA – Get Rating) will post $159.10 million in sales for the current fiscal quarter, according to Zacks. Five analysts have provided estimates for Sabra Health Care REIT’s earnings. The lowest sales estimate is $156.30 million and the highest is $161.40 million. Sabra Health Care REIT posted sales of $152.93 million during the same quarter last year, which suggests a positive year over year growth rate of 4%. The company is expected to issue its next quarterly earnings report on Monday, January 1st.
On average, analysts expect that Sabra Health Care REIT will report full year sales of $643.48 million for the current year, with estimates ranging from $633.70 million to $655.40 million. For the next fiscal year, analysts expect that the business will report sales of $660.64 million, with estimates ranging from $635.15 million to $693.90 million. Zacks’ sales calculations are a mean average based on a survey of sell-side analysts that that provide coverage for Sabra Health Care REIT.
Sabra Health Care REIT (NASDAQ:SBRA – Get Rating) last announced its quarterly earnings data on Wednesday, May 4th. The real estate investment trust reported $0.18 earnings per share for the quarter, topping the consensus estimate of $0.17 by $0.01. Sabra Health Care REIT had a negative return on equity of 3.15% and a negative net margin of 18.28%. During the same quarter in the previous year, the company posted $0.39 earnings per share.
SBRA has been the subject of several recent research reports. Capital One Financial initiated coverage on Sabra Health Care REIT in a report on Friday. They set an “equal weight” rating and a $15.50 price objective for the company. Mizuho raised Sabra Health Care REIT from a “neutral” rating to a “buy” rating and dropped their price objective for the stock from $16.00 to $15.00 in a report on Wednesday, May 25th. Credit Suisse Group boosted their target price on Sabra Health Care REIT from $14.00 to $15.00 and gave the stock a “neutral” rating in a research report on Monday, April 4th. StockNews.com began coverage on Sabra Health Care REIT in a research report on Thursday, March 31st. They set a “hold” rating for the company. Finally, Bank of America upgraded Sabra Health Care REIT from an “underperform” rating to a “neutral” rating and set a $15.00 target price for the company in a research report on Friday, March 11th. Seven equities research analysts have rated the stock with a hold rating and five have issued a buy rating to the company. Based on data from MarketBeat, Sabra Health Care REIT has a consensus rating of “Hold” and a consensus price target of $15.95.
Shares of NASDAQ:SBRA opened at $13.49 on Tuesday. The stock has a market capitalization of $3.12 billion, a P/E ratio of -27.53 and a beta of 1.42. Sabra Health Care REIT has a 1-year low of $11.44 and a 1-year high of $19.01. The company has a current ratio of 3.60, a quick ratio of 3.60 and a debt-to-equity ratio of 0.70. The business has a 50-day moving average price of $13.24 and a two-hundred day moving average price of $13.44.
The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, May 31st. Investors of record on Monday, May 16th were given a $0.30 dividend. The ex-dividend date of this dividend was Friday, May 13th. This represents a $1.20 annualized dividend and a dividend yield of 8.90%. Sabra Health Care REIT’s dividend payout ratio is presently -244.89%.
Several institutional investors and hedge funds have recently modified their holdings of the stock. Voya Investment Management LLC grew its position in shares of Sabra Health Care REIT by 0.4% in the 3rd quarter. Voya Investment Management LLC now owns 187,382 shares of the real estate investment trust’s stock valued at $2,758,000 after purchasing an additional 734 shares during the period. US Bancorp DE grew its position in shares of Sabra Health Care REIT by 17.7% in the 3rd quarter. US Bancorp DE now owns 5,533 shares of the real estate investment trust’s stock valued at $81,000 after purchasing an additional 831 shares during the period. State of Alaska Department of Revenue grew its position in shares of Sabra Health Care REIT by 0.6% in the 4th quarter. State of Alaska Department of Revenue now owns 149,160 shares of the real estate investment trust’s stock valued at $2,019,000 after purchasing an additional 897 shares during the period. Cetera Investment Advisers lifted its stake in Sabra Health Care REIT by 1.2% in the 1st quarter. Cetera Investment Advisers now owns 80,608 shares of the real estate investment trust’s stock valued at $1,200,000 after acquiring an additional 919 shares in the last quarter. Finally, Xponance Inc. lifted its stake in Sabra Health Care REIT by 2.9% in the 4th quarter. Xponance Inc. now owns 34,248 shares of the real estate investment trust’s stock valued at $464,000 after acquiring an additional 957 shares in the last quarter. Institutional investors and hedge funds own 91.61% of the company’s stock.
Sabra Health Care REIT Company Profile (Get Rating)
As of September 30, 2020, Sabra’s investment portfolio included 425 real estate properties held for investment (consisting of (i) 287 Skilled Nursing/Transitional Care facilities, (ii) 64 Senior Housing communities (ÂSenior Housing – LeasedÂ), (iii) 47 Senior Housing communities operated by third-party property managers pursuant to property management agreements (ÂSenior Housing – ManagedÂ) and (iv) 27 Specialty Hospitals and Other facilities), one asset held for sale, one investment in a direct financing lease, 19 investments in loans receivable (consisting of (i) one mortgage loan, (ii) one construction loan and (iii) 17 other loans), six preferred equity investments and one investment in an unconsolidated joint venture that owns 158 Senior Housing – Managed communities.
Featured Stories
Get a free copy of the Zacks research report on Sabra Health Care REIT (SBRA)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Sabra Health Care REIT Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Sabra Health Care REIT and related companies with MarketBeat.com’s FREE daily email newsletter.
Source: defenseworld.net
